Cargando…
Regulating Immunogenicity and Tolerogenicity of Bone Marrow-Derived Dendritic Cells through Modulation of Cell Surface Glycosylation by Dexamethasone Treatment
Dendritic cellular therapies and dendritic cell vaccines show promise for the treatment of autoimmune diseases, the prolongation of graft survival in transplantation, and in educating the immune system to fight cancers. Cell surface glycosylation plays a crucial role in the cell–cell interaction, up...
Autores principales: | Lynch, Kevin, Treacy, Oliver, Gerlach, Jared Q., Annuk, Heidi, Lohan, Paul, Cabral, Joana, Joshi, Lokesh, Ryan, Aideen E., Ritter, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670353/ https://www.ncbi.nlm.nih.gov/pubmed/29163502 http://dx.doi.org/10.3389/fimmu.2017.01427 |
Ejemplares similares
-
Functional Ambivalence of Dendritic Cells: Tolerogenicity and Immunogenicity
por: Nam, Ji-Hee, et al.
Publicado: (2021) -
Tolerogenic dendritic cells are efficiently generated using minocycline and dexamethasone
por: Lee, Jae-Hee, et al.
Publicado: (2017) -
Costimulatory Molecules on Immunogenic Versus Tolerogenic Human Dendritic Cells
por: Hubo, Mario, et al.
Publicado: (2013) -
Role of the Immunogenic and Tolerogenic Subsets of Dendritic Cells in Multiple Sclerosis
por: Xie, Zhong-Xiang, et al.
Publicado: (2015) -
Lactoferrin Induces Tolerogenic Bone Marrow-Derived Dendritic Cells
por: Park, Hui-Won, et al.
Publicado: (2020)